Saghmos Therapeutics reposted this
We are excited to announce Saghmos Therapeutics' participation at the Morgan Stanley 22nd Annual Global Healthcare Conference, to be held at the New York Marriott Marquis. Please join me and Stephen Grant MD, Former Deputy Director, FDA, Division of Cardiology and Nephrology and currently our Chief Regulatory Officer, on Wednesday, September 4th at 2:35 pm Eastern Time to learn more about our Phase 3-ready cardiovascular-kidney metabolic asset, ST-62516, for reducing the risk of cardiorenal complications after PCI. We will host 1-on-1 meetings September 4-6th at the conference; you can reach us via Morgan Stanley conference platform or LinkedIn message. The presentation will be webcast live at: https://lnkd.in/e6mxQ8jm, with a replay available shortly thereafter.
All the best ! This will be such a great asset for patients !!! Thank you and all the scientists for their hard work and commitment